4CMenB Vaccination Effective Against Invasive Meningococcal Disease in Children Under 5
Vaccine effectiveness with at least one dose was 64 percent against serogroup B, 82 percent against non-serogroup B disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.